A61K 31/197
The amino and the carboxyl groups being attached to the same acyclic
Official title: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
A61K31/197 (The amino and the carboxyl groups being attached to the same acyclic) appears on 5,492 US grants and 10,756 published applications in this corpus.
Search patents in A61K- Granted patents
- 5,492
- Published applications
- 10,756
- Assignees
- 3,693
- Inventors
- 15,070
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 19 | 0 |
| 1996 | 27 | 0 |
| 1997 | 60 | 0 |
| 1998 | 68 | 0 |
| 1999 | 78 | 0 |
| 2000 | 68 | 0 |
| 2001 | 89 | 36 |
| 2002 | 86 | 159 |
| 2003 | 97 | 246 |
| 2004 | 63 | 285 |
| 2005 | 69 | 304 |
| 2006 | 70 | 297 |
| 2007 | 70 | 280 |
| 2008 | 65 | 235 |
| 2009 | 59 | 261 |
| 2010 | 99 | 322 |
| 2011 | 112 | 320 |
| 2012 | 143 | 304 |
| 2013 | 207 | 401 |
| 2014 | 255 | 545 |
| 2015 | 253 | 538 |
| 2016 | 290 | 529 |
| 2017 | 333 | 569 |
| 2018 | 315 | 488 |
| 2019 | 338 | 553 |
| 2020 | 327 | 588 |
| 2021 | 325 | 685 |
| 2022 | 338 | 652 |
| 2023 | 301 | 618 |
| 2024 | 297 | 570 |
| 2025 | 312 | 501 |
| 2026 | 230 | 470 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Stable levothyroxine compositions in aprotic polar solvents6 Oct 2026US 12,751,937 B2Xeris Pharmaceuticals, Inc.
- Synergistic activity of novel compounds against planktonic and biofilm cells of clinically relevant pathogens6 Oct 2026US 12,752,038 B2SterileCare Inc.
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Compounds and formulations29 Sep 2026US 12,746,248 B2Pro-Al Medico-Technologies, Inc.
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Tea compositions comprising paraxanthine and methods of production thereof8 Oct 2026US 2026/0305643 A1
- Perfluorocarbon compositions, systems, and methods for ischemic, inflammatory, infectuous, transplant, and other medical conditions8 Oct 2026US 2026/0306422 A1
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Methods and devices for treating plumonary vasoconstriction and asthma251US 5,485,827 AThe General Hospital Corporation · 1996
- Personal safety mobile notification system229US 8,624,727 B2Saigh and Son, LLC · 2014
- Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions198US 7,048,906 B2Cedars-Sinai Medical Center · 2006
- Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors183US 6,133,320 ABoard of Regents, The University of Texas System · 2000